BRADLEY HOMZA: Open Payments
NPI 1932789435 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 91 payments from 16 companies in 2025. Trend: 2023 $1,115 · 2024 $1,151 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $209 |
| Lilly USA, LLC | 16 | $176 |
| ABBVIE INC. | 21 | $165 |
| Exact Sciences Corporation | 7 | $138 |
| GlaxoSmithKline, LLC. | 13 | $137 |
| Novo Nordisk Inc | 8 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| PFIZER INC. | 3 | $52 |
| KYOWA KIRIN, INC. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $32 |
Products named: FARXIGA, Cologuard Collection Kit, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, QULIPTA, VRAYLAR, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
